Geert Cauwenbergh
Oprichter bij Phases 123 LLC
Actieve functies van Geert Cauwenbergh
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Expressive Constructs, Inc.
Expressive Constructs, Inc. Pharmaceuticals: OtherHealth Technology Expressive Constructs, Inc. researches and develops antibody detection technologies. The company's products include diagnostic sensor for urinary tract infections and wound care systems that provide warning of emergent infections and promote healing. It was founded by Mitch Sanders in 1998 and is headquartered in Worcester, MA. | Voorzitter | 01-02-2011 | - |
Directeur/Bestuurslid | 20-01-2010 | 02-02-2011 | |
Phases 123 LLC | Oprichter | 25-04-2011 | - |
Corporate Officer/Principal | 01-02-2011 | - | |
Cutanea Life Sciences, Inc.
Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA. | Directeur/Bestuurslid | 01-09-2011 | - |
Alto Pharmaceuticals Ltd.
Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada. | Directeur/Bestuurslid | - | - |
Legacy Healthcare (Switzerland) SA
Legacy Healthcare (Switzerland) SA Pharmaceuticals: MajorHealth Technology Legacy Healthcare (Switzerland) SA is a biopharmaceutical company based in Switzerland. The Swiss company was founded by Saad Harti and he has been the CEO since incorporation. | Directeur/Bestuurslid | - | - |
Loopbaan van Geert Cauwenbergh
Eerdere bekende functies van Geert Cauwenbergh
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PHIO PHARMACEUTICALS CORP. | Directeur/Bestuurslid | 27-04-2012 | 20-07-2023 |
Algemeen Directeur | 04-05-2022 | 29-09-2022 | |
Financieel Directeur/CFO | 04-05-2022 | 29-09-2022 | |
Independent Dir/Board Member | 29-09-2022 | 20-07-2023 | |
President | 27-04-2012 | 14-11-2018 | |
MOBERG PHARMA AB | Directeur/Bestuurslid | 23-04-2012 | 15-05-2019 |
Independent Dir/Board Member | 23-04-2012 | 15-05-2019 | |
AVECHO BIOTECHNOLOGY LIMITED | Directeur/Bestuurslid | 03-03-2014 | 30-05-2017 |
Independent Dir/Board Member | 03-03-2014 | 30-05-2017 | |
ABLYNX | Directeur/Bestuurslid | 05-04-2010 | 25-04-2013 |
Independent Dir/Board Member | 01-01-2007 | 25-04-2013 | |
░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ ░ ░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░ ░░░░░░░ ░░░░░░░░ ░ ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░ ░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Opleiding van Geert Cauwenbergh
Université Catholique de Louvain | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 14 |
België | 5 |
Frankrijk | 2 |
Operationeel
Director/Board Member | 12 |
Chief Executive Officer | 5 |
Chairman | 4 |
Sectoraal
Health Technology | 14 |
Finance | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
CALETHOS, INC. | Finance |
PHIO PHARMACEUTICALS CORP. | Health Technology |
MOBERG PHARMA AB | Health Technology |
AVECHO BIOTECHNOLOGY LIMITED | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Bedrijven in privébezit | 16 |
---|---|
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Expressive Constructs, Inc.
Expressive Constructs, Inc. Pharmaceuticals: OtherHealth Technology Expressive Constructs, Inc. researches and develops antibody detection technologies. The company's products include diagnostic sensor for urinary tract infections and wound care systems that provide warning of emergent infections and promote healing. It was founded by Mitch Sanders in 1998 and is headquartered in Worcester, MA. | Health Technology |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
Johnson & Johnson Consumer & Personal Care | |
Johnson & Johnson Holdco (NA), Inc.
Johnson & Johnson Holdco (NA), Inc. Household/Personal CareConsumer Non-Durables Johnson & Johnson Consumer, Inc. manufactures health and skin care products. It offers wide variety of lotion, moisturizing cream, baby wash, shampoo and conditioner, baby powder and bath, hand and face wipes, soap, baby oil and cologne. The company was founded on March 8, 2016 and is headquartered in Skillman, NJ. | Consumer Non-Durables |
Phases 123 LLC | |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Health Technology |
RHEI Pharmaceuticals HK Ltd. | |
Center for Medical Innovation | |
DARA BioSciences, Inc.
DARA BioSciences, Inc. Pharmaceuticals: MajorHealth Technology DARA BioSciences, Inc. is a pharmaceutical company focused on the development and commercialization of oncology treatment and supportive care products. The company's product portfolio includes Soltamox, Gelclair, Bionect and KRN5500. Soltamox offers a choice to patients who prefer or need a liquid form of tamoxifen. Gelclair is an alcohol-free bioadherent oral rinse gel for rapid and effective relief of pain associated with oral mucositis caused by chemotherapy and radiation treatment. The company markets Bionect, a topical treatment for skin irritation and burns associated with radiation therapy, in U.S. oncology/radiology markets. DARA BioSciences was founded by Steven Gorlin on June 22, 2002 and is headquartered in Raleigh, NC. | Health Technology |
Cutanea Life Sciences, Inc.
Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA. | Health Technology |
Alto Pharmaceuticals Ltd.
Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Alto Pharmaceuticals Ltd. Develops and commercialize products for maintaining a healthy lifestyle and improving quality of life. The firm’s area of interest includes dermatology and skin care, as well as post surgical support. The company was founded by Joan Chypyha in 2008 and is headquartered in Oakridges, Canada. | Health Technology |
Aramis LLC | |
Legacy Healthcare (Switzerland) SA
Legacy Healthcare (Switzerland) SA Pharmaceuticals: MajorHealth Technology Legacy Healthcare (Switzerland) SA is a biopharmaceutical company based in Switzerland. The Swiss company was founded by Saad Harti and he has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Geert Cauwenbergh
- Ervaring